Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Dec 10
Love0

Treatment of Actinic Keratoses With 5% Topical Imiquimod: A Multicenter Prospective Observational Study from 93 Austrian Office-based Dermatologists

By No Comments
INTRODUCTIONTherapy of actinic keratosis (AK) using imiquimod 5% cream (Aldara, MEDA Pharmaceuticals, Somerset, NJ) was approved in the United States and European Union in 2005 and 2006, respectively. Despite the…
Read More
Dec 10
Love0

Trends in Primary Skin Cancer Prevention Among US Hispanics: A Systematic Review

By No Comments
INTRODUCTION Hispanics represent the largest and fastest growing minority group in the United States. Over the past decade the Hispanic population has increased by 43% and now accounts for 16.3%…
Read More
Dec 10
Love0

In Vitro PLK1 Inhibition by BI 2536 Decreases Proliferation and Induces Cell-Cycle Arrest in Melanoma Cells

By No Comments
INTRODUCTIONHuman cutaneous malignant melanoma is one of the most resistant tumors to treat, being responsible for 75% of skin cancer-related deaths.1Despite improvements in the management of this tumor, its treatment…
Read More
Dec 10
Love0

Evaluation of the Chemopreventative Effects of ALA PDT in Patients With Multiple Actinic Keratoses and a History of Skin Cancer

By No Comments
INTRODUCTIONDiscrete actinic keratoses (AKs) may be treated by cryosurgery with liquid nitrogen, curettage with electrodessication, topical creams (imiquimod, 5-fluorouracil, diclofenac), or surgery; however, targeted therapeutic modalities are not as effective…
Read More
Dec 10
Love0

Diclofenac Sodium 3% Gel for the Management of Actinic Keratosis: 10+ Years of Cumulative Evidence of Efficacy and Safety

By No Comments
INTRODUCTIONActinic keratosis (AK) is a chronic disease and part of a biologic continuum between photodamaged skin and invasive squamous cell carcinoma (SCC).1 Long-term management is required for AK because photodamage…
Read More
Dec 10
Love0

Sarcoidosis as an Adverse Effect of Tumor Necrosis Factor Inhibitors

By No Comments
INTRODUCTIONTumor necrosis factor (TNF) inhibitors are a relatively new treatment used for a wide variety of inflammatory skin diseases. As their use increases, the prevalence of rare adverse events also…
Read More
Dec 10
Love0

Improved Texture and Appearance of Human Facial Skin After Daily Topical Application of Barley Produced, Synthetic, Human-like Epidermal Growth Factor (EGF) Serum

By No Comments
INTRODUCTION Present in a wide variety of tissues and fluids, epidermal growth factor protein (EGF) acts on a subset of the tyrosine kinase receptor family.1 Epidermal growth factor serves primarily…
Read More
Dec 10
Love0

Where Does Rituximab Fit in the Treatment of Autoimmune Mucocutaneous Blistering Skin Disease?

By No Comments
INTRODUCTION Scientific evidence supporting the optimal treatment for autoimmune mucocutaneous blistering diseases (AMBD) today has not been established.1 High dose systemic corticosteroids are often cited as first line therapy. Because…
Read More
Dec 10
Love0

Lessons of Leprosy: The Emergence of TH17 Cytokines During Type II Reactions (ENL) Is Teaching Us About T-cell Plasticity

By No Comments
INTRODUCTION Frank Macfarlane Burnet won the Nobel Prize for the clonal selection theory of immunity in 1960. 1 In 1961, Miller published evidence that these lymphocyte "clones" were educated in…
Read More
Dec 10
Love0

A Comparison of Physicochemical Properties of a Selection of Modern Moisturizers: Hydrophilic Index and pH

By No Comments
INTRODUCTIONAvast array of choices are available for skin moisturizers, making the selection process an overwhelming task for both consumers and health care practitioners. Despite this problem, few studies have compared…
Read More
Dec 10
Love0

Biophysical Evaluation of Fractional Laser Skin Resurfacing With an Er:YSGG Laser Device in Japanese Skin

By No Comments
INTRODUCTION The fractional laser skin resurfacing (FLSR) system is a new skin treatment concept using multiple microscopic laser beams.1,2 The two main types of FLSR systems currently available are ablative…
Read More
Dec 10
Love0

Fitzpatrick Skin Types and Clindamycin Phosphate 1.2%/Benzoyl Peroxide Gel: Efficacy and Tolerability of Treatment in Moderate to Severe Acne

By No Comments
People of color represent the fastest-growing segment of the US population. In 2000, they represented less than one-third of the nation's total population. By 2050, U.S. Census estimates suggest that…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • Level Up Your Dermoscopy Skills April 28, 2026
  • Decoding Derm: What’s the Diagnosis? April 27, 2026
  • An Investigator-Developed Regimen for Treatment and Prevention of Post-Inflammatory Hyperpigmentation in Skin of Color April 24, 2026
  • Exosome-Based Therapies in Dermatology: A Scoping Review April 23, 2026
  • Randomized-Controlled Trial Comparing Safety and Efficacy of Repairing Balm vs Topical Antimicrobial for Post-Procedural Wounds April 22, 2026

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |     ADVERTISING POLICY  |    MANAGE PREFERENCES  |  YOUR PRIVACY CHOICES

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search

  • x-twitter
  • facebook
  • linkedin
  • instagram